SCHEMBL3469402

SCHEMBL3469402

COc1ccc(I)n2nc(C3(C(N)=O)CC3)nc12

nearest known ligand 0.58

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 7/20 0.58
PDE4D Q08499 13/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17571398 0.89 PDE4D (0.48) PDE4APDE4D
SCHEMBL508221 0.89 PDE4D (0.59) PDE4APDE4D
SCHEMBL10165149 0.86 PDE4A (0.48) PDE4APDE4D
SCHEMBL509637 0.84 PDE4D (0.59) PDE4APDE4D
SCHEMBL509400 0.83 PDE4A (0.61) PDE4APDE4D
SCHEMBL509401 0.81 PDE4A (0.64) PDE4APDE4D
SCHEMBL3469602 0.79 PDE4A (0.52) PDE4APDE4D
SCHEMBL3469404 0.79 PDE4D (0.47) PDE4APDE4D
SCHEMBL510059 0.78 PDE4A (0.59) PDE4APDE4D
SCHEMBL508899 0.77 PDE4D (0.67) PDE4APDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379548-B1 TRIAZOLOPYRIDINES AS PHOSPHODIESTERASE INHIBITORS FOR TREATMENT OF DERMAL DISEASES LEO PHARMA AS (DK) 2016-03-09 EP disclosed
US-8952162-B2 Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases LEO PHARMA A/S (DK) 2015-02-10 US disclosed
WO-2010069322-A1 TRIAZOLOPYRIDINES AS PHOSPHODIESTERASE INHIBITORS FOR TREATMENT OF DERMAL DISEASES LEO PHARMA A/S (DK) 2010-06-24 WO disclosed